HUP0204231A2 - Eljárás hCG tisztítására és az eljárással tisztított rekombináns hCG - Google Patents

Eljárás hCG tisztítására és az eljárással tisztított rekombináns hCG

Info

Publication number
HUP0204231A2
HUP0204231A2 HU0204231A HUP0204231A HUP0204231A2 HU P0204231 A2 HUP0204231 A2 HU P0204231A2 HU 0204231 A HU0204231 A HU 0204231A HU P0204231 A HUP0204231 A HU P0204231A HU P0204231 A2 HUP0204231 A2 HU P0204231A2
Authority
HU
Hungary
Prior art keywords
hcg
purification
exchange chromatography
recombinant
ion
Prior art date
Application number
HU0204231A
Other languages
English (en)
Inventor
Gianfranco Paradisi
Mara Rossi
Laura Scaglia
Original Assignee
Applied Research Systems, ARS Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems, ARS Holding N.V. filed Critical Applied Research Systems, ARS Holding N.V.
Priority to HUP1300063 priority Critical patent/HU1300063D0/hu
Publication of HUP0204231A2 publication Critical patent/HUP0204231A2/hu
Publication of HUP0204231A3 publication Critical patent/HUP0204231A3/hu
Publication of HU228935B1 publication Critical patent/HU228935B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)

Abstract

A CHO-sejtek felülúszójából származó, nyers, rekombináns, emberichorionális gonadotropint (hCG) tartalmazó, mintákból történőrekombináns hCG tisztítására szolgáló folyamatban ioncserélő-kromatográfiát és fordított fázisú HPLC-t kombinálva alkalmaznak. Akétszer végzett ioncserélő-kromatográfia és mint végső lépés, améretkizárásos-kromatográfia, lehetővé teszi, hogy tisztítás során aszennyező anyagoktól teljesen megszabaduljanak. A tisztítási folyamateredményeként kapott nagytisztaságú hCG specifikus bioaktivitásakülönösen magas, körülbelül 25 000 NE/mg. A találmány tárgyát képeziktovábbá eljárással előállított hCG terápiásan hatékony mennyiségét ésalkalmas adalékanyagot tartalmazó gyógyászati készítmények. Ó
HU0204231A 2000-02-22 2001-01-22 Process of purification of hcg and recombinant hcg purified by that method HU228935B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HUP1300063 HU1300063D0 (hu) 2000-02-22 2001-01-22 Tisztított hCG

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103690 2000-02-22
PCT/EP2001/000665 WO2001062773A1 (en) 2000-02-22 2001-01-22 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD

Publications (3)

Publication Number Publication Date
HUP0204231A2 true HUP0204231A2 (hu) 2003-03-28
HUP0204231A3 HUP0204231A3 (en) 2005-09-28
HU228935B1 HU228935B1 (en) 2013-06-28

Family

ID=8167925

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0204231A HU228935B1 (en) 2000-02-22 2001-01-22 Process of purification of hcg and recombinant hcg purified by that method
HUP1300063 HU1300063D0 (hu) 2000-02-22 2001-01-22 Tisztított hCG

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUP1300063 HU1300063D0 (hu) 2000-02-22 2001-01-22 Tisztított hCG

Country Status (32)

Country Link
US (2) US7297777B2 (hu)
EP (2) EP1257564B1 (hu)
JP (1) JP4588960B2 (hu)
KR (1) KR100806911B1 (hu)
CN (1) CN100482679C (hu)
AT (1) ATE406378T1 (hu)
AU (2) AU783320B2 (hu)
BG (1) BG65807B1 (hu)
BR (1) BRPI0108556B8 (hu)
CA (1) CA2399020A1 (hu)
CY (1) CY1108460T1 (hu)
CZ (1) CZ303144B6 (hu)
DE (1) DE60135541D1 (hu)
DK (1) DK1257564T3 (hu)
EA (1) EA006605B1 (hu)
EE (1) EE05644B1 (hu)
ES (1) ES2307585T3 (hu)
HK (1) HK1052016A1 (hu)
HR (1) HRP20020650B1 (hu)
HU (2) HU228935B1 (hu)
IL (2) IL151308A0 (hu)
ME (1) ME00296B (hu)
MX (1) MXPA02007871A (hu)
NO (1) NO328694B1 (hu)
PL (1) PL205149B1 (hu)
PT (1) PT1257564E (hu)
RS (1) RS50741B (hu)
SI (1) SI1257564T1 (hu)
SK (1) SK287146B6 (hu)
UA (2) UA78488C2 (hu)
WO (1) WO2001062773A1 (hu)
ZA (1) ZA200206109B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006605B1 (ru) * 2000-02-22 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. СПОСОБ ОЧИСТКИ РЕКОМБИНАНТНОГО чХГ
JP2007513192A (ja) * 2004-10-04 2007-05-24 ノベタイド，リミティド ペプチド用の対イオン交換法
CN1958603B (zh) * 2005-11-04 2010-05-05 上海天伟生物制药有限公司 一种人绒毛膜促性腺素的纯化方法
WO2008007993A1 (fr) * 2006-07-11 2008-01-17 Koval, Anton Alexandrovich Utilisation d'une hormone chorionique ou lutéinisante destinée à la prévention ou au traitement de l'hypogonadisme lié à l'âge
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN101792481B (zh) * 2010-03-12 2012-05-30 丽珠医药集团股份有限公司 一种绒毛膜***的纯化方法
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
WO2012131306A1 (en) 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
WO2013102921A2 (en) * 2011-11-17 2013-07-11 Sanzyme Limited Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm)
CN103288950A (zh) * 2012-12-28 2013-09-11 青岛九龙生物医药有限公司 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种***的纯度测定方法
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN111233999B (zh) * 2020-03-21 2024-02-23 上海浦东明炎生物技术有限公司 一种从人尿中提取人绒毛膜***的方法
CN113398251B (zh) * 2021-07-30 2022-08-05 宁波人健药业集团股份有限公司 一种重组人绒毛膜***冻干粉针剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0461200T3 (da) * 1989-02-21 1997-03-10 Univ Washington Modificerede former af reproduktionshormoner
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1254370B (it) * 1992-05-22 1995-09-14 Sorin Biomedica Spa Procedimento per la purificazione di proteine da sistemi cellulari.
DK0814841T3 (da) 1995-03-21 2002-03-04 Applied Research Systems Flydende hCG-formuleringer
EA002474B1 (ru) * 1996-02-20 2002-06-27 Апплайд Резеч Системз Арс Холдинг Н.В. Гибридный белок, образующий гетеродимеры, способ его получения и использования
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
WO1998056806A1 (en) 1997-06-12 1998-12-17 The Regents Of The University Of California A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP
ES2287976T3 (es) * 1997-06-13 2007-12-16 Genentech, Inc. Recuperacion de proteinas mediante cromatografia seguida de filtracion sobre una capa cargada.
US6583109B1 (en) * 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
EA006605B1 (ru) * 2000-02-22 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. СПОСОБ ОЧИСТКИ РЕКОМБИНАНТНОГО чХГ

Also Published As

Publication number Publication date
DE60135541D1 (de) 2008-10-09
EA200200892A1 (ru) 2003-02-27
EA006605B1 (ru) 2006-02-24
BR0108556A (pt) 2003-01-28
US20070299001A1 (en) 2007-12-27
ATE406378T1 (de) 2008-09-15
EE200200469A (et) 2004-04-15
BG65807B1 (bg) 2009-12-31
HRP20020650B1 (en) 2011-02-28
PT1257564E (pt) 2008-09-10
CY1108460T1 (el) 2014-04-09
IL151308A (en) 2009-11-18
CZ20022855A3 (cs) 2002-11-13
JP4588960B2 (ja) 2010-12-01
IL151308A0 (en) 2003-04-10
BRPI0108556B8 (pt) 2021-05-25
NO20023985L (no) 2002-08-21
RS50741B (sr) 2010-08-31
CA2399020A1 (en) 2001-08-30
UA78488C2 (en) 2007-04-10
SK287146B6 (sk) 2010-01-07
CN100482679C (zh) 2009-04-29
HU228935B1 (en) 2013-06-28
US7297777B2 (en) 2007-11-20
NO328694B1 (no) 2010-04-26
EP1257564B1 (en) 2008-08-27
CZ303144B6 (cs) 2012-05-02
UA86938C2 (uk) 2009-06-10
YU60202A (sh) 2005-09-19
AU2006200059A1 (en) 2006-02-02
KR20030001359A (ko) 2003-01-06
ME00296B (me) 2011-05-10
HRP20020650A2 (en) 2004-12-31
SK12062002A3 (sk) 2002-12-03
US20030104553A1 (en) 2003-06-05
WO2001062773A1 (en) 2001-08-30
NO20023985D0 (no) 2002-08-21
PL357508A1 (en) 2004-07-26
HU1300063D0 (hu) 2003-03-28
SI1257564T1 (sl) 2008-12-31
MEP38908A (en) 2011-02-10
DK1257564T3 (da) 2008-10-06
MXPA02007871A (es) 2003-02-10
BRPI0108556B1 (pt) 2015-04-14
ZA200206109B (en) 2003-07-31
KR100806911B1 (ko) 2008-02-22
PL205149B1 (pl) 2010-03-31
EP1752466A3 (en) 2012-10-10
CN1404485A (zh) 2003-03-19
JP2003524015A (ja) 2003-08-12
AU2680401A (en) 2001-09-03
AU783320B2 (en) 2005-10-13
EE05644B1 (et) 2013-04-15
BG107000A (en) 2003-04-30
HK1052016A1 (en) 2003-08-29
EP1257564A1 (en) 2002-11-20
ES2307585T3 (es) 2008-12-01
EP1752466A2 (en) 2007-02-14
HUP0204231A3 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
HUP0204231A2 (hu) Eljárás hCG tisztítására és az eljárással tisztított rekombináns hCG
PL400575A1 (pl) Sposób wytwarzania oczyszczonej daptomycyny, sposób oczyszczania daptamycyny, kompozycja daptamycyny, zastosowanie kompozycji farmaceutycznej oraz izolowany zwiazek
HUP0301814A2 (hu) Tisztított LH
HUP0103502A2 (hu) Streptococcus Cbéta-fehérje készítmények
RU2005118752A (ru) Позиционные изомеры пэгилированного интерферона l-2а (конъюгата пэг-ifn-l-2а)
AR042019A1 (es) N-acetilgalactosamina-4-sulfatasa precursora, composiciones farmaceuticas que la contienen , metodos de tratamiento que la utilizan y metodos para producirla y purificarla
WO2002004487A3 (de) Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
IL182830A0 (en) Purification of recombinant human factor xiii
NZ516235A (en) Method for purification of proteins

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: MERCK SERONO S.A., CH

Free format text: FORMER OWNER(S): APPLIED RESEARCH SYSTEMS, ARS HOLDING N.V., NL; LABORATOIRES SERONO SA, CH